CRAMS to global pharma companies, give good returns
The pharma sector may have underperformed in the Sensex , but companies providing contract research and manufacturing services (CRAMS) to global pharma companies have given good returns.
Pharma
IBM targets multi-billion $ health sector in India
IBM is targeting multi-billion dollar health business opportunities in India. The company has plans to tap opportunities worth $1 billion each in the Indian pharmaceuticals and health service segments over the next 3-4 years.
Citi Venture Capital picks up 30% in Unimark
US-based private equity fund Citi Venture Capital (CVC) has picked up nearly 30% stake in Mumbai-based bulk drug maker Unimark Remedies for INR 113 crore. The transaction, one of the largest investments in the pharma sector in 2007 and CVC
Ranbaxy may dilute 60% in new R&D unit
Ranbaxy Laboratories may dilute up to 60% stake in its new research company, which will be formed by hiving off its R&D unit into a separate entity in 2008.
NPIL, Merck in research deal for cancer drugs
Nicholas Piramal (NPIL) has reportedly signed a research deal potentially worth a maximum revenue of USD 350 million with US pharmaceutical giant Merck & Co to carry out early discovery and development of two new cancer drugs, the two companies said on Monday.
Sops for pharma cos might extend to 2015
Drug makers can hope for tax sops for research activities to continue till 2015. Thus, consumers can hope for some reduction in the prices of drugs across the board and particularly in the case of cancer and HIV/AIDs drugs soon.
Dr Reddy’s plans to ramp up R&D spend
Indian pharmaceutical major Dr Reddy
PCI urges health ministry to amend Pharmacy Act
To enhance the standards of millions of pharmacists in the country, the Pharmacy Council of India (PCI) has urged the Health Ministry to amend the Pharmacy Act to make CEP (continuing education programme) mandatory for registration and subsequent renewal under the Pharmacy Act.
India’s Manipal AcuNova acquires German firm Ecron
Clinical research firm Manipal AcuNova Ltd recently announced it has completed the acquisition of ECRON GmbH, Europe.
Orchid adopts Lorenz eCTD solution (docuBridge)
The LORENZ Life Sciences Group announced recently that Orchid Chemicals & Pharmaceuticals, located in Chennai, India has chosen docuBridge as its eCTD Publishing and Management solution.
Needle-free insulin soon in India
Biotechnology company Shreya Lifesciences has entered into an in-licensing agreement with US-based Generex Biotechnology Corp to market Oral-lyn, the country
India’s Pharma industry to grow at 16%: KPMG
A report from research firm KPMG predicts that the domestic pharmaceutical industry is projected to grow by 16 per cent annually for the next five years, three percentage points more than the current growth rate.
Private Equity investments in pharma touch $400 m
Private Equity (PE) investments in the domestic healthcare and pharma industry have touched around $400 million during the first nine months of the year. This trend is set to accelerate as companies go for overseas acquisitions, hive off their R&D units, and Foreign Currency Convertible Bonds (FCCB) lose their sheen.
